AJJ Medtech HoldingsSGX:584 FCF Yield % is -14.50 as of Jul. 12, 2026. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, AJJ Medtech Holdings ranks worse than 78.83% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for AJJ Medtech Holdings's FCF Yield % or its related term are showing as below:
SGX:584'
s FCF Yield % Range Over the Past 10 Years
Min: -107.89 Med: -32.37 Max: -2.66
Current: -14.5
During the past 13 years, the highest FCF Yield % of AJJ Medtech Holdings was -2.66%. The lowest was -107.89%. And the median was -32.37%.
SGX:584's FCF Yield % is ranked worse than 78.83% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.42
vs SGX:584: -14.50
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AJJ Medtech Holdings FCF Yield % Related Terms
AJJ Medtech Holdings FCF Yield % Historical Data
* Premium members only.
The historical data trend for AJJ Medtech Holdings's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AJJ Medtech Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AJJ Medtech Holdings FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AJJ Medtech Holdings's FCF Yield % distribution charts can be found below:
* The bar in red indicates where AJJ Medtech Holdings's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AJJ Medtech Holdings (SGX:584) has a FCF Yield % of -14.50 as of Jul. 12, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AJJ Medtech Holdings and its competitors. According to the industry distribution chart, AJJ Medtech Holdings ranks #674 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 78.8%.
Is AJJ Medtech Holdings' FCF Yield % too high?
AJJ Medtech Holdings' current FCF Yield % is -14.50. Based on the distribution chart, AJJ Medtech Holdings ranks #674 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does AJJ Medtech Holdings' FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AJJ Medtech Holdings ranks #674 out of 855 companies for FCF Yield %. This places AJJ Medtech Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AJJ Medtech Holdings and its competitors. AJJ Medtech Holdings's current FCF Yield % is -14.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
Based on GuruFocus' analysis, AJJ Medtech Holdings (SGX:584) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.01, compared to a current price of S$0.01 — trading 50% below its estimated fair value. The current FCF Yield % is -14.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current FCF Yield % is -14.50 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:584 has been successfully added to your 